亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Early metabolic acidosis in critically ill patients: a binational multicentre study

作者
Katsunori Mochizuki,Tomoko Fujii,Eldho Mathew Paul,Matthew Anstey,David V. Pilcher,Rinaldo Bellomo
出处
期刊:Critical Care and Resuscitation [Elsevier BV]
卷期号:23 (1): 67-75 被引量:24
标识
DOI:10.51893/2021.1.oa6
摘要

Metabolic acidosis (MA) is a major physiological derangement associated with mortality.1 There is no specific treatment for MA, beyond treating its cause.However, the administration of buffering solutions to correct MA may be common practice in the intensive care unit (ICU).The rationale for such therapy is that, independent of its cause, MA with acidaemia impairs the performance of the cardiovascular system 2,3 and should be corrected.To reduce this perceived cardiovascular dysfunction, sodium bicarbonate is the most commonly used agent.4,5 However, until recently there have been little or no data on its effectiveness.6,7 In 2018, Jaber and colleagues 8 reported the findings of a multicentre, open-label, randomised controlled trial of the efficacy of intravenous sodium bicarbonate for critically ill patients with severe MA (BICAR-ICU trial).The trial investigators found that the administration of sodium bicarbonate reduced the use of renal replacement therapy (RRT) in the ICU, and decreased 28-day mortality in the subgroup of patients with acute kidney injury Stage 2 and 3.These findings have created renewed interest in the use of sodium bicarbonate for MA.However, it is unclear how many patients such an intervention would apply to and what the outcome of such patients in the setting of usual care might be.Moreover, for the purpose of designing and powering a trial, it is unknown whether investigators should apply more moderate criteria for MA to achieve more efficient patient selection.In particular, patients with moderate MA may also have a high mortality risk and a much greater prevalence than severe MA.This larger population would then enable the conduct of a trial with greater external validity and with recruitment that is more efficient.Accordingly, the aim of the study was to measure the incidence, prevalence, characteristics and outcomes of patients with both severe MA (using the BICAR-ICU trial criteria) and moderate MA (using new criteria) in Australian and New Zealand ICUs.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研猫发布了新的文献求助10
1秒前
淡淡的志泽完成签到,获得积分10
1秒前
合适怜南完成签到,获得积分10
1秒前
3秒前
3秒前
渡增越发布了新的文献求助10
5秒前
5秒前
6秒前
6秒前
6秒前
7秒前
lysteph发布了新的文献求助10
8秒前
五十二赫兹完成签到 ,获得积分10
10秒前
寒冷的爆米花关注了科研通微信公众号
12秒前
April完成签到,获得积分10
13秒前
summer完成签到,获得积分10
15秒前
h11的应助被渡增越采纳,获得10
16秒前
17秒前
染8完成签到 ,获得积分10
17秒前
TBI发布了新的文献求助10
18秒前
VV2001完成签到,获得积分10
18秒前
20秒前
ddwdwdwdddw发布了新的文献求助10
22秒前
fuzhenwei完成签到 ,获得积分10
24秒前
26秒前
生动火龙果完成签到 ,获得积分10
27秒前
跳跃奇异果完成签到 ,获得积分10
27秒前
h11的应助被jiang采纳,获得10
29秒前
研猫发布了新的文献求助10
31秒前
fuzhenwei关注了科研通微信公众号
32秒前
平淡水之完成签到,获得积分10
34秒前
37秒前
ddwdwdwdddw完成签到,获得积分10
37秒前
Lucas的应助被科研通管家采纳,获得10
38秒前
ding的应助被科研通管家采纳,获得10
38秒前
Lucas的应助被科研通管家采纳,获得10
38秒前
ccczzz完成签到,获得积分10
39秒前
桴子完成签到,获得积分10
39秒前
40秒前
41秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158533
求助须知:如何正确求助?哪些是违规求助? 9554333
关于积分的说明 21718908
捐赠科研通 7748056
什么是DOI,文献DOI怎么找? 3427015
关于科研通互助平台的介绍 2551841
邀请新用户注册赠送积分活动 2471242